Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness
JAMA Netw Open
.
2022 Jul 1;5(7):e2224172.
doi: 10.1001/jamanetworkopen.2022.24172.
Authors
Brittany M Gouse
1
2
,
Hannah E Brown
1
2
Affiliations
1
Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts.
2
Department of Psychiatry, Boston Medical Center, Boston, Massachusetts.
PMID:
35900769
DOI:
10.1001/jamanetworkopen.2022.24172
No abstract available
Publication types
Comment
MeSH terms
Antipsychotic Agents* / therapeutic use
Cognition
Delayed-Action Preparations / therapeutic use
Humans
Schizophrenia* / drug therapy
Substances
Antipsychotic Agents
Delayed-Action Preparations